350 related articles for article (PubMed ID: 22421328)
1. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
[TBL] [Abstract][Full Text] [Related]
3. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
[TBL] [Abstract][Full Text] [Related]
4. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
[TBL] [Abstract][Full Text] [Related]
5. First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospital.
Soudani A; Hadjfredj S; Zribi M; Messaoud T; Masmoudi A; Majed B; Fendri C
Clin Microbiol Infect; 2010 Sep; 16(9):1454-7. PubMed ID: 19845696
[TBL] [Abstract][Full Text] [Related]
6. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
Huang TS; Kunin CM; Shin-Jung Lee S; Chen YS; Tu HZ; Liu YC
J Antimicrob Chemother; 2005 Dec; 56(6):1058-62. PubMed ID: 16204341
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
[TBL] [Abstract][Full Text] [Related]
8. gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China.
Long Q; Li W; Du Q; Fu Y; Liang Q; Huang H; Xie J
Int J Antimicrob Agents; 2012 Jun; 39(6):486-9. PubMed ID: 22526012
[TBL] [Abstract][Full Text] [Related]
9. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
12. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
13. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
Kim JM; Kim JS; Kim N; Jung HC; Song IS
J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
Matrat S; Veziris N; Mayer C; Jarlier V; Truffot-Pernot C; Camuset J; Bouvet E; Cambau E; Aubry A
Antimicrob Agents Chemother; 2006 Dec; 50(12):4170-3. PubMed ID: 17015625
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
Rimbara E; Noguchi N; Kawai T; Sasatsu M
Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
17. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
Cheng AF; Yew WW; Chan EW; Chin ML; Hui MM; Chan RC
Antimicrob Agents Chemother; 2004 Feb; 48(2):596-601. PubMed ID: 14742214
[TBL] [Abstract][Full Text] [Related]
18. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
19. Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China.
Yin X; Yu Z
J Infect; 2010 Jul; 61(2):150-4. PubMed ID: 20452372
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
Sun Z; Zhang J; Zhang X; Wang S; Zhang Y; Li C
Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]